Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Amgen
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Men and women between the ages of 18 and 65 years old
Diagnosis of SLE
Stable disease; defined as no change in SLE therapy within the previous 30 days. Up to 5 mg/day incremental changes of prednisone therapy is allowed during the 30 days prior to randomization
SLE disease duration of at least 1 year, as diagnosed by a physician
You may not be if
Current renal disease
Signs or symptoms of viral or bacterial infection within 30 days of enrollment
Any disorder (including psychiatric), condition or clinically significant disease (other than a diagnosis of SLE) that would interfere the study evaluation, completion and/or procedures per the investigator's discretion
Administration of more than 10 mg/day prednison (or equivalent) in the 30 days prior to randomization
